BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37162344)

  • 1. Diagnostic Performance of BD Phoenix CPO Detect Panels for Detection and Classification of Carbapenemase-Producing Gram-Negative Bacteria.
    Murata M; Kosai K; Akamatsu N; Matsuyama Y; Oda M; Wakamatsu A; Izumikawa K; Mukae H; Yanagihara K
    Microbiol Spectr; 2023 Jun; 11(3):e0089723. PubMed ID: 37162344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance evaluation of automated BD Phoenix NMIC-500 panel for carbapenemase detection in carbapenem-resistant and carbapenem-susceptible Enterobacterales.
    Cho H; Kim JO; Choi JE; Lee H; Heo W; Cha YJ; Yoo IY; Park YJ
    J Microbiol Methods; 2020 Oct; 177():106042. PubMed ID: 32890572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the BD Phoenix CPO Detect Panel for Detection and Classification of Carbapenemase Producing
    Lade H; Jeong S; Jeon K; Kim HS; Kim HS; Song W; Kim JS
    Antibiotics (Basel); 2023 Jul; 12(7):. PubMed ID: 37508311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the BD Phoenix CPO Detect Test for the detection of carbapenemase-producing Enterobacterales.
    Ozyurt OK; Cetinkaya O; Ozhak B; Ongut G; Turhan O; Yazisiz H; Donmez L; Kuskucu MA; Midilli K; Ogunc D
    Future Microbiol; 2023 May; 18():399-405. PubMed ID: 37256285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter Evaluation of the BD Phoenix CPO Detect Test for Detection and Classification of Carbapenemase-Producing Organisms in Clinical Isolates.
    Whitley V; Kircher S; Gill T; Hindler JA; O'Rourke S; Cooper C; Tulpule A; Denys GA
    J Clin Microbiol; 2020 Apr; 58(5):. PubMed ID: 32132195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of the BD Phoenix CPO detect assay for detection and classification of carbapenemase-producing organisms.
    Berneking L; Both A; Berinson B; Hoffmann A; Lütgehetmann M; Aepfelbacher M; Rohde H
    Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):979-985. PubMed ID: 33245470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the BD Phoenix Carbapenemase-Producing Organism Panels for the Detection of Carbapenemase Producers in
    Correa-León YP; Pérez-Hernández JM; Martinez-Guerra BA; Rodríguez-Noriega E; Mena-Ramírez JP; López-Gutiérrez E; López-Jácome LE; Monroy-Colin VA; Mireles-Davalos CD; Padilla-Ibarra C; Quevedo-Ramos MA; Feliciano-Guzmán JM; Pérez-Vicelis T; Velázquez-Acosta MDC; Hernández-Durán M; Garza-González E
    Diagnostics (Basel); 2023 Nov; 13(22):. PubMed ID: 37998553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance Evaluation of the Newly Developed BD Phoenix NMIC-500 Panel Using Clinical Isolates of Gram-Negative Bacilli.
    Park BY; Mourad D; Hong JS; Yoon EJ; Kim D; Lee H; Jeong SH
    Ann Lab Med; 2019 Sep; 39(5):470-477. PubMed ID: 31037866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the automated BD Phoenix CPO Detect panel in combination with the β-CARBA assay for detection and classification of carbapenemase-producing Enterobacterales.
    Simon M; Gatermann S; Pfeifer Y; Reischl U; Gessner A; Jantsch J
    J Microbiol Methods; 2019 Jan; 156():29-33. PubMed ID: 30521867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the BD Phoenix CPO detect panel for prediction of Ambler class carbapenemases.
    Jonas D; Reuter S; Klassen S; Weber S; Buck M; Giani T; Rossolini GM; Grundmann H
    Sci Rep; 2021 Jun; 11(1):13150. PubMed ID: 34162904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the automated BD Phoenix CPO Detect test for detection and classification of carbapenemases in Gram negatives.
    Saad Albichr I; Anantharajah A; Dodémont M; Hallin M; Verroken A; Rodriguez-Villalobos H
    Diagn Microbiol Infect Dis; 2020 Feb; 96(2):114911. PubMed ID: 31753520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Accuracy of BD Phoenix CPO Detect for Carbapenemase Production in 190 Enterobacteriaceae Isolates.
    Ong CH; Ratnayake L; Ang MLT; Lin RTP; Chan DSG
    J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30209186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Stringency Evaluation of the Automated BD Phoenix CPO Detect and Rapidec Carba NP Tests for Detection and Classification of Carbapenemases.
    Thomson G; Turner D; Brasso W; Kircher S; Guillet T; Thomson K
    J Clin Microbiol; 2017 Dec; 55(12):3437-3443. PubMed ID: 28978681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance Evaluation of BD Phoenix NMIC-413 Antimicrobial Susceptibility Testing Panel for Imipenem, Meropenem, and Ertapenem Against Clinical Carbapenem-Resistant and Carbapenem-Susceptible
    Zhang J; Jia P; Zhu Y; Zhang G; Xu Y; Yang Q
    Front Med (Lausanne); 2021; 8():643194. PubMed ID: 33937287
    [No Abstract]   [Full Text] [Related]  

  • 15. Performance Evaluation of Diagnostic Assays for Detection and Classification of Carbapenemase-Producing Organisms.
    Zhang A; Wang X; Liang X; Zhou C; Wang Q; Zhang J; Wang H
    Antibiotics (Basel); 2021 Nov; 10(12):. PubMed ID: 34943669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of carbapenemase-producing Enterobacterales and the BD Phoenix CPO Detect panel.
    Simon M; Koestler J; Reischl U; Gessner A; Jantsch J
    Expert Rev Mol Diagn; 2019 Aug; 19(8):659-665. PubMed ID: 31314606
    [No Abstract]   [Full Text] [Related]  

  • 17. Extended-spectrum Beta-lactamase detection with different panels for automated susceptibility testing and with a chromogenic medium.
    Färber J; Moder KA; Layer F; Tammer I; König W; König B
    J Clin Microbiol; 2008 Nov; 46(11):3721-7. PubMed ID: 18845821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the BD Phoenix™ CPO Detect Test for the detection of carbapenemase producers.
    Croxatto A; Coste AT; Pillonel T; Bertelli C; Greub G; Prod'hom G
    Clin Microbiol Infect; 2020 May; 26(5):644.e9-644.e15. PubMed ID: 31634549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid identification from rectal swabs of the clinically most relevant carbapenemase genes from gram-negative bacteria using the BD MAX Check-Points CPO Assay.
    García-Fernández S; Simner PJ; Thomson G; Faron M; Bosboom R; van Griethuijsen A; García-Castillo M; Harris R; Ledeboer NA; Cantón R; Thomson KS
    Diagn Microbiol Infect Dis; 2022 Jan; 102(1):115554. PubMed ID: 34678712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct comparison of the BD phoenix system with the MicroScan WalkAway system for identification and antimicrobial susceptibility testing of Enterobacteriaceae and nonfermentative gram-negative organisms.
    Snyder JW; Munier GK; Johnson CL
    J Clin Microbiol; 2008 Jul; 46(7):2327-33. PubMed ID: 18495856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.